Clinical Trials Logo

Clinical Trial Summary

This study is part of a national vision to fight against serophobia and support society towards more ethical and benevolent practices vis-à-vis aging and specific populations. The main objective of this study is to assess over the past five years the prevalence of people living with the Human Immunodeficiency Virus (HIV) aged 60 years and over and its evolution within the Paris Region medico-social structures


Clinical Trial Description

The aim objective of this study is to identify patients living with the Human Immunodeficiency Virus (HIV) in medical and social strutures in Île-de-France, in order to question them, in particular about their life courses and how they are treated and supported now. This study also query family caregivers of seropositive seniors and profiessional caregivers. This trial is designed in two parts: - The one consists to quantify and describe patient's clinical and social profil: Age, sex, authonomy level, medical data related to HIV infoection, Chronic deseases, social and economic data will be collected at 5 and 3 years before inclusion, at inclusion, at 1 and 2 yeans after inclusion - Then a second qualitative part which allow to query seropositive patients about their fagility and comorbidities, and to identify the impact of these on their life and social relation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05135689
Study type Observational
Source Gérond'if
Contact Isabelle Dufour
Phone +33 (0)185781010
Email isabelle.dufour@gerondif.org
Status Recruiting
Phase
Start date September 22, 2021
Completion date October 2024

See also
  Status Clinical Trial Phase
Completed NCT01910493 - Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique N/A
Completed NCT01296113 - Chemotherapy for Lung Cancer in HIV-positive Patients Phase 2